The first FANCJ mutants to be studied were missense variants (P47A, M299I; Figure 2) identified in individuals with early breast cancer and normal genotypes for BRCA1 or BRCA2 (Cantor et al., 2001). Here, BRIP1 is linked to breast carcinoma.